Workflow
操纵证券市场!300亿A股控股股东,被判刑

Core Viewpoint - The controlling shareholder and former chairman of Meihua Biological, Meng Qingshan, has been sentenced to three years in prison with a five-year probation for manipulating the securities market, following a fine of 122 million yuan [2][5]. Group 1: Legal Proceedings - On November 7, Meihua Biological announced that it received a written notification from Meng Qingshan regarding the court's judgment, which sentenced him to three years in prison, with a five-year probation, and imposed a fine [5][6]. - Meng Qingshan has not held any position in the company since his retirement in January 2017 and only exercises shareholder rights at the shareholder meeting level [6]. Group 2: Previous Penalties - Meng Qingshan was previously fined and had 122 million yuan confiscated due to his involvement in market manipulation [7]. - The China Securities Regulatory Commission (CSRC) had previously investigated Meng Qingshan for illegal activities, leading to administrative penalties [8]. Group 3: Details of Market Manipulation - The investigation revealed that Meng Qingshan and Yang Huixing manipulated the stock price of Meihua Biological during a non-public stock issuance in 2013, ensuring its success by providing guarantees for trust plans [9]. - The illegal gains from their actions amounted to 196 million yuan for the trust involved, with actual losses of 140 million yuan incurred by a shareholder [9][10]. - The CSRC determined that Meng Qingshan's actions violated the Securities Law and imposed a ten-year market ban along with the confiscation of illegal gains [10].